In a recent column, you noted that many patients do not properly use their inhaled asthma/chronic obstructive pulmonary ...
An asthma treatment that only requires patients to have two jabs a year to prevent life-threatening attacks will be available ...
Marketed as Exdensur, the ultra-long-acting biologic is the first of its kind, requiring only two injections per year to ...
Indiana University School of Medicine researchers are taking a closer look at how young patients respond to biologic ...
AQI levels in Delhi crossed 400, in the severe category, on Tuesday, with several monitoring stations in the 'severe plus' ...
The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.
Trials of a new asthma drug show that it could prove life changing for many people – who would only need two jabs a year. The ...
The FDA approved depemokimab as an add-on maintenance treatment in patients aged at least 12 years with severe asthma and an ...
A 19-year-old in Lucknow received financial support from a Reddit user to buy asthma medication after sharing his struggles ...
The U.S. Food and Drug Administration has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for severe ...
The U.S. health regulator has approved GSK's add-on treatment for severe asthma, offering a less frequently dosed option, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback